Morton Grove Pharmaceuticals, a generics manufacturer and subsidiary of Mumbai-based drug company Wockhardt, has agreed to discontinue all manufacturing, processing and drug distribution from its Illinois site after the Department of Justice accused it of selling adulterated drugs.
Enforcement Report - Week of September 29, 2021
Enforcement Report - Week of December 30, 2020
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 21 abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Enforcement Report - Week of August 15, 2018
Enforcement Report - Week of September 6, 2017
The US FDA has warned Wockhardt Limited about operations at its US subsidiary Morton Grove Pharmaceuticals Inc.
Wockhardt dipped nearly 7% to Rs 701 on the BSE in early morning trade after the pharmaceutical company said that its step-down unit in the US, Morton Grove Pharmaceuticals Inc., has received a warning letter from the US Food and Drug Administration (FDA).
Morton Grove Pharmaceuticals, Inc. Recalls Lindane Lotion, USP 1% due to Super-Potent Drug
India`s Wockhardt Faces Mass Of Lawsuits In U.S. Over Generic Reglan